Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass 2021-10-20 21:00
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology 2021-10-20 18:00
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China 2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer 2021-10-19 23:30
Excelra Announces Addition of Sudip Nandy to its Board of Directors 2021-10-19 21:00
Moët Hennessy Breaks New Ground For Innovation: The Robert-Jean De Vogüé Research Center 2021-10-19 21:00
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease 2021-10-19 17:52
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick 2021-10-19 15:01
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections 2021-10-19 09:00
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge 2021-10-19 06:51
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications 2021-10-18 20:00
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers 2021-10-18 11:05
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046 2021-10-18 10:19
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams 2021-10-18 09:00
UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture 2021-10-16 05:04
Novavax to Participate in World Vaccine Congress Europe 2021-10-16 04:39
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
1 179 180 181 182 183 415